Fras-le Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

61.2%

Verhouding schuld/eigen vermogen

R$1.26b

Schuld

Rente dekkingsratio	-4x
Contant	R$1.39b
Aandelen	R$2.06b
Totaal verplichtingen	R$2.42b
Totaal activa	R$4.48b

Recente financiële gezondheidsupdates

Recent updates

Fras-le S.A.'s (BVMF:FRAS3) Business Is Yet to Catch Up With Its Share Price

Oct 03

Fras-le S.A.'s (BVMF:FRAS3) Share Price Not Quite Adding Up

Jun 26

Shareholders Will Be Pleased With The Quality of Fras-le's (BVMF:FRAS3) Earnings

Mar 18

Fras-le (BVMF:FRAS3) Has A Rock Solid Balance Sheet

Dec 15

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

Oct 25

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

Jun 07

Fras-le S.A. (BVMF:FRAS3) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 26

Is There Now An Opportunity In Fras-le S.A. (BVMF:FRAS3)?

Jan 28

We Think Fras-le (BVMF:FRAS3) Can Stay On Top Of Its Debt

Jun 05

Why Fras-le S.A. (BVMF:FRAS3) Could Be Worth Watching

May 18

Is Fras-le (BVMF:FRAS3) A Risky Investment?

Feb 17

Did You Participate In Any Of Fras-le's (BVMF:FRAS3) Fantastic 251% Return ?

Feb 02

Do Institutions Own Fras-le S.A. (BVMF:FRAS3) Shares?

Jan 18

Is Fras-le S.A.'s (BVMF:FRAS3) 5.5% ROE Strong Compared To Its Industry?

Jan 03

Factors Income Investors Should Consider Before Adding Fras-le S.A. (BVMF:FRAS3) To Their Portfolio

Dec 07

We Wouldn't Rely On Fras-le's (BVMF:FRAS3) Statutory Earnings As A Guide

Nov 18

Did You Participate In Any Of Fras-le's (BVMF:FRAS3) Fantastic 108% Return ?

Sep 25

Investor Optimism Abounds Fras-le S.A. (BVMF:FRAS3) But Growth Is Lacking

Sep 07

Something To Consider Before Buying Fras-le S.A. (BVMF:FRAS3) For The 7.8% Dividend

Aug 19

Does Fras-le's (BVMF:FRAS3) Statutory Profit Adequately Reflect Its Underlying Profit?

Jul 27

Here's What Fras-le S.A.'s (BVMF:FRAS3) Shareholder Ownership Structure Looks Like

Jul 10

Fras-le Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Fras-le (BVMF:FRAS3) Has A Rock Solid Balance Sheet

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

We Think Fras-le (BVMF:FRAS3) Can Stay On Top Of Its Debt

Is Fras-le (BVMF:FRAS3) A Risky Investment?

Recent updates

Fras-le S.A.'s (BVMF:FRAS3) Business Is Yet to Catch Up With Its Share Price

Price target increased by 11% to R$23.44

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings released: EPS: R$0.15 (vs R$0.36 in 2Q 2023)

Fras-le S.A.'s (BVMF:FRAS3) Share Price Not Quite Adding Up

First quarter 2024 earnings released: EPS: R$0.40 (vs R$0.34 in 1Q 2023)

Upcoming dividend of R$0.13 per share

Shareholders Will Be Pleased With The Quality of Fras-le's (BVMF:FRAS3) Earnings

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Fras-le S.A., Annual General Meeting, Apr 17, 2024

Fras-le (BVMF:FRAS3) Has A Rock Solid Balance Sheet

Consensus EPS estimates increase by 15%

Consensus EPS estimates increase by 23%

Price target increased by 12% to R$16.90

Second quarter 2023 earnings released: EPS: R$0.37 (vs R$0.28 in 2Q 2022)

Fras-le S.A. to Report Q3, 2023 Results on Nov 08, 2023

First quarter 2023 earnings released: EPS: R$0.34 (vs R$0.13 in 1Q 2022)

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Price target decreased by 11% to R$16.63

No independent directors

Third quarter 2022 earnings released: EPS: R$0.28 (vs R$0.39 in 3Q 2021)

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

Second quarter 2022 earnings released

Investor sentiment improved over the past week

Fras-le (BVMF:FRAS3) Has A Pretty Healthy Balance Sheet

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

No independent directors

Upcoming dividend of R$0.11 per share

Investor sentiment deteriorated over the past week

Fras-le S.A. (BVMF:FRAS3) Just Reported And Analysts Have Been Lifting Their Price Targets

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Fras-le S.A., Annual General Meeting, Apr 12, 2022

Is There Now An Opportunity In Fras-le S.A. (BVMF:FRAS3)?

Second quarter 2021 earnings released: EPS R$0.20 (vs R$0.065 in 2Q 2020)

Investor sentiment improved over the past week

We Think Fras-le (BVMF:FRAS3) Can Stay On Top Of Its Debt

Why Fras-le S.A. (BVMF:FRAS3) Could Be Worth Watching

Inaugural dividend of R$0.10 per share

Full year 2020 earnings released: EPS R$0.88 (vs R$0.17 in FY 2019)

Fras-le S.A. to Report Q4, 2020 Results on Mar 03, 2021

Is Fras-le (BVMF:FRAS3) A Risky Investment?

New 90-day high: R$11.22

Did You Participate In Any Of Fras-le's (BVMF:FRAS3) Fantastic 251% Return ?

Do Institutions Own Fras-le S.A. (BVMF:FRAS3) Shares?

Is Fras-le S.A.'s (BVMF:FRAS3) 5.5% ROE Strong Compared To Its Industry?

New 90-day high: R$9.79

New 90-day high: R$8.59

Factors Income Investors Should Consider Before Adding Fras-le S.A. (BVMF:FRAS3) To Their Portfolio

We Wouldn't Rely On Fras-le's (BVMF:FRAS3) Statutory Earnings As A Guide

Third quarter 2020 earnings released: EPS R$0.061

New 90-day high: R$7.24

Market bids up stock over the past week

New 90-day high: R$6.20

New 90-day high: R$5.87

Fras-le S.A. (BOVESPA:FRAS3) completed the acquisition of Nakata Automotiva from Osasco.

Did You Participate In Any Of Fras-le's (BVMF:FRAS3) Fantastic 108% Return ?

New 90-day high: R$5.70

Investor Optimism Abounds Fras-le S.A. (BVMF:FRAS3) But Growth Is Lacking

Something To Consider Before Buying Fras-le S.A. (BVMF:FRAS3) For The 7.8% Dividend

Fras-le S.A. to Report Q3, 2020 Results on Nov 11, 2020

Does Fras-le's (BVMF:FRAS3) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day high - R$5.64

Here's What Fras-le S.A.'s (BVMF:FRAS3) Shareholder Ownership Structure Looks Like

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven